Physician

Chad Robbins Brodt, MD

According to 2025 Medicare claims, Chad Brodt, MD (NPI: 1164696035) practices cardiac electrophysiology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Mateo, CA. This provider's primary affiliated billing organization is SUTTER BAY MEDICAL FOUNDATION (NPI: 1013950807; TIN: 941156581) and primary practice location at 94062-2751. Brodt is affiliated with the Sutter Medicare Direct (ACO ID: A5279), participating under the MSSP model.

Brodt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 968 traditional Medicare patients, billed 4,148 HCPCS/CPT codes, and received $472,269 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 1,184 prescription claims across 207 beneficiaries totaling $423,437 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 113 records totaling $112,698. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $67,211 to $472,269. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $10,912 and ending at $423,437. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	493	782	$67,211
2017	963	2,170	$185,003
2018	1,216	2,686	$208,028
2019	1,167	2,679	$217,901
2020	290	1,673	$159,419
2021	364	2,327	$298,025
2022	507	2,965	$434,323
2023	915	3,957	$463,224
2024	968	4,148	$472,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	68	$10,912
2016	93	249	$41,033
2017	224	1,182	$278,657
2018	247	1,423	$409,894
2019	227	1,146	$489,618
2020	145	513	$208,042
2021	85	327	$101,257
2022	133	594	$163,636
2023	184	956	$332,861
2024	207	1,184	$423,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	156	158	$613
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	343	694	$158
93623	Programming of heart rhythm stimulation after drug infusion	166	169	$48
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	183	210	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	465	737	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	159	11,557	$216,403
Xarelto	Rivaroxaban	45	2,915	$53,194
Jardiance	Empagliflozin	31	2,490	$47,879
Dofetilide	Dofetilide	48	3,720	$23,314
Corlanor	Ivabradine Hcl	21	899	$22,101

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$73,278	ATRICURE, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	8	$39,420	Impulse Dynamics (USA) Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chad Robbins Brodt, MD?

Tedicare shows public-source Medicare data for Chad Robbins Brodt, MD (NPI 1164696035), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chad Robbins Brodt, MD have ACO affiliation data?

Chad Robbins Brodt, MD is shown with ACO affiliation data for Sutter Medicare Direct (MSSP, ACO ID A5279).

What billing organization is linked to Chad Robbins Brodt, MD?

Chad Robbins Brodt, MD is linked to SUTTER BAY MEDICAL FOUNDATION (billing NPI 1013950807) in the available physician profile data.

Does Chad Robbins Brodt, MD have Open Payments data?

Chad Robbins Brodt, MD has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.